Lanreotide_Other_Varieties

Name：Lanreotide

Indication：Acromegaly,neuroendocrine tumors

CAS No.:108736-35-2

Molecular formula: C54H69N11O10S2

Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. Its sequence is H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2.

Lanreotide (as lanreotide acetate) is manufactured by Ipsen, and marketed under the trade name Somatuline. It is available in several countries, including the United Kingdom, Australia and Canada, and was approved for sale in the United States by the Food and Drug Administration (FDA) on August 30, 200

we are peptides powder manufacturer of lanreotide from china.

https://www.tcspeptides.com/html/product/2020-12-30/52.html